{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Brain+Ischemia&page=2", "query": { "condition": "Brain Ischemia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Brain+Ischemia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-26T12:45:29.730Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04818944", "title": "Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Ischemic Stroke", "Ischemic Stroke" ], "interventions": [ { "name": "Tirofiban Hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2023-03-01", "completion_date": "2025-09-01", "has_results": false, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04818944" }, { "nct_id": "NCT06511934", "title": "Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brainstem Stroke", "ALS", "Tetraplegia", "Spinal Cord Injuries", "Cervical Spinal Cord Injury" ], "interventions": [ { "name": "BrainGate Neural Interface System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Leigh R. Hochberg, MD, PhD.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 6, "start_date": "2024-07-22", "completion_date": "2027-07-30", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06511934" }, { "nct_id": "NCT07556939", "title": "Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study). The LUCID Device is Used in the Treatment of Ischemic Brain Reperfusion Injury Caused by Cardiac Arrest in Pediatric Patients.", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Reperfusion Injury", "Post Cardiac Arrest Brain Injury" ], "interventions": [ { "name": "LUTICIA - Light Utilization COX-Inhibitory Device)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Mitovation, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "48 Hours", "maximum_age": "1 Year", "sex": "ALL", "summary": "48 Hours to 1 Year" }, "enrollment_count": 30, "start_date": "2026-07-15", "completion_date": "2030-07-15", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07556939" }, { "nct_id": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukodystrophy", "White Matter Disease", "Leukoencephalopathies", "4H Syndrome", "Adrenoleukodystrophy", "AMN", "ALD", "ALD Gene Mutation", "ALD (Adrenoleukodystrophy)", "X-linked Adrenoleukodystrophy", "X-ALD", "Adrenomyeloneuropathy", "Aicardi Goutieres Syndrome", "AGS", "Alexander Disease", "Alexanders Leukodystrophy", "AxD", "ADLD", "Canavan Disease", "CTX", "Cerebrotendinous Xanthomatoses", "Krabbe Disease", "GALC Deficiency", "Globoid Leukodystrophy", "TUBB4A-Related Leukodystrophy", "H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum", "HBSL", "HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity", "LBSL", "Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder)", "Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation", "ALSP", "CSF1R Gene Mutation", "HCC - Hypomyelination and Congenital Cataract", "MLC1", "Megalencephalic Leukoencephalopathy With Subcortical Cysts", "MLD", "Metachromatic Leukodystrophy", "PMD", "Pelizaeus-Merzbacher Disease", "PLP1 Null Syndrome", "PLP1 Gene Duplication | Blood or Tissue | Mutations", "Pelizaeus Merzbacher Like Disease", "Peroxisomal Biogenesis Disorder", "Zellweger Syndrome", "Refsum Disease", "Salla Disease", "Sialic Storage Disease", "Sjögren", "Sjogren-Larsson Syndrome", "Van Der Knapp Disease", "Vanishing White Matter Disease", "Charcot-Marie-Tooth", "CMT", "Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency", "Allan-Herndon-Dudley Syndrome", "Cadasil", "Cockayne Syndrome", "Multiple Sulfatase Deficiency", "Gangliosidoses", "GM2 Gangliosidosis", "BPAN", "Labrune Syndrome", "LCC", "Mucopolysaccharidoses", "TBCK-Related Intellectual Disability Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12000, "start_date": "2016-12-08", "completion_date": "2030-12-08", "has_results": false, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 23, "location_summary": "Los Angeles, California • Orange, California • Palo Alto, California + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03047369" }, { "nct_id": "NCT00041938", "title": "Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Disease", "Stroke", "Ischemic Heart Disease", "Myocardial Infarction" ], "interventions": [ { "name": "aspirin", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2305, "start_date": "2002-10", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2014-09-05", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 54, "location_summary": "Tucson, Arizona • Santa Clara, California • West Los Angeles, California + 41 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Santa Clara", "state": "California" }, { "city": "West Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041938" }, { "nct_id": "NCT02922452", "title": "A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ischemic Stroke" ], "interventions": [ { "name": "BMS-986141", "type": "DRUG" }, { "name": "Dilitazem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 16, "start_date": "2016-09", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2016-12-20", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02922452" }, { "nct_id": "NCT00164658", "title": "Evaluating Tools for Health Promotion and Disease Prevention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Coronary Heart Disease", "Stroke", "Diabetes", "Breast Cancer", "Ovarian Cancer", "Colorectal Cancer" ], "interventions": [ { "name": "Familial risk assessment and personalized prevention messages", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 8400, "start_date": "2005-09", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2010-01-07", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 3, "location_summary": "Evanston, Illinois • Leawood, Kansas • Ann Arbor, Michigan", "locations": [ { "city": "Evanston", "state": "Illinois" }, { "city": "Leawood", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00164658" }, { "nct_id": "NCT06778226", "title": "ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke" ], "interventions": [], "intervention_types": [], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4827, "start_date": "2018-01-01", "completion_date": "2026-04-22", "has_results": false, "last_update_posted_date": "2026-05-11", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 3, "location_summary": "Miami, Florida • Boston, Massachusetts • Providence, Rhode Island", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT06778226" }, { "nct_id": "NCT00630396", "title": "Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stroke, Acute" ], "interventions": [ { "name": "Minocycline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Hess, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 60, "start_date": "2008-05", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2012-01-13", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 2, "location_summary": "Lexington, Kentucky • Portland, Oregon", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00630396" }, { "nct_id": "NCT00250991", "title": "Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "activase", "type": "DRUG" }, { "name": "integrilin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 94, "start_date": "2003-07", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2009-05-08", "last_synced_at": "2026-06-26T12:45:29.730Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Los Angeles, California • Santa Monica, California + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Edgewood", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00250991" } ] }